Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8421 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8421 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8346 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8346 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8309 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8309 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8296 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8244 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.8222 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8182 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.8182 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.8175 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7898 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD8252 |
Approved |
0.7898 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7895 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7863 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7848 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.7762 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7708 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7698 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7671 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7647 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7643 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7591 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7584 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7582 |
Intermediate Similarity |
NPD1934 |
Approved |
0.758 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7569 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7569 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7561 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7561 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7548 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7547 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7538 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7538 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7533 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7519 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7518 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD5494 |
Approved |
0.75 |
Intermediate Similarity |
NPD3705 |
Approved |
0.75 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7442 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7436 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7436 |
Intermediate Similarity |
NPD6788 |
Approved |
0.7429 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7419 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.74 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.74 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7397 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7386 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7364 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7353 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7353 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7328 |
Intermediate Similarity |
NPD228 |
Approved |
0.7325 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7324 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7317 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7285 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD6830 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7266 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7261 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7248 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7244 |
Intermediate Similarity |
NPD37 |
Approved |
0.7239 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7234 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7229 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7226 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7215 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7215 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7215 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7214 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7208 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7206 |
Intermediate Similarity |
NPD6581 |
Approved |
0.7206 |
Intermediate Similarity |
NPD6580 |
Approved |
0.7205 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7197 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7195 |
Intermediate Similarity |
NPD7054 |
Approved |
0.719 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7178 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7172 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7162 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7162 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7161 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7153 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7153 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7153 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7125 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7089 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7086 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.707 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7063 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7059 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7059 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7045 |
Intermediate Similarity |
NPD8095 |
Phase 1 |
0.7037 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.703 |
Intermediate Similarity |
NPD7228 |
Approved |
0.703 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7027 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7027 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7027 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7027 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7027 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7023 |
Intermediate Similarity |
NPD290 |
Approved |
0.7021 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7021 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7021 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7019 |
Intermediate Similarity |
NPD919 |
Approved |
0.7014 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7007 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7007 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7007 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6986 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6985 |
Remote Similarity |
NPD2557 |
Approved |
0.6981 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6978 |
Remote Similarity |
NPD17 |
Approved |
0.6974 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6972 |
Remote Similarity |
NPD7258 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6957 |
Remote Similarity |
NPD7533 |
Approved |
0.6957 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6957 |
Remote Similarity |
NPD7534 |
Approved |
0.6954 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6939 |
Remote Similarity |
NPD3620 |
Phase 2 |
0.6939 |
Remote Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.6939 |
Remote Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.6934 |
Remote Similarity |
NPD3596 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD1247 |
Approved |
0.6923 |
Remote Similarity |
NPD5976 |
Discontinued |
0.6918 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.6917 |
Remote Similarity |
NPD3022 |
Approved |
0.6917 |
Remote Similarity |
NPD3021 |
Approved |
0.6913 |
Remote Similarity |
NPD2200 |
Suspended |
0.6908 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6908 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6908 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD4162 |
Approved |
0.6908 |
Remote Similarity |
NPD4237 |
Approved |
0.6906 |
Remote Similarity |
NPD3445 |
Approved |
0.6906 |
Remote Similarity |
NPD3443 |
Approved |
0.6906 |
Remote Similarity |
NPD5691 |
Approved |
0.6906 |
Remote Similarity |
NPD3444 |
Approved |
0.6905 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6903 |
Remote Similarity |
NPD1424 |
Approved |
0.6903 |
Remote Similarity |
NPD4123 |
Phase 3 |
0.6903 |
Remote Similarity |
NPD4584 |
Approved |
0.6901
|
Remote Similarity |
NPD6543 |
Approved |